Extract to table

Leverett, Partner), with its offices at 125 High Street, Suite 800, Boston, MA 02110; WHEREAS, the Investor has reviewed the Confidential Private Placement Memorandum of the Fund dated as of June 2, 2025 (the "Memorandum"), and the Partnership Agreement, and has had the opportunity to ask questions of the General Partner regarding the Fund, its investment strategy, and the terms and conditions of the offering; and WHEREAS, capitalized terms used but not defined herein shall have the meanings ascribed to them in the Partnership Agreement

2 In the event of any conflict between this Side Letter and the Partnership Agreement, the terms of this Side Letter shall control solely with respect to the Investor

3 This Side Letter shall not be construed to amend, modify, or otherwise affect the terms of the Partnership Agreement as applied to any limited partner other than the Investor

4 Except as expressly modified herein, the Partnership Agreement shall remain in full force and effect with respect to the Investor, and the Investor shall remain subject to all obligations, restrictions, and limitations applicable to limited partners under the Partnership Agreement

The General Partner further acknowledges that the Investor has a legitimate and substantial interest in structuring its investment in the Fund so as to minimize or eliminate its exposure to UBTI, and the General Partner agrees to cooperate with the Investor in achieving that objective as set forth in this Section 2

(b) The General Partner agrees that the Investor shall have the right to invest its Commitment, in whole or in part, through one or more of the following structures: (i) HGF V blocker Corp